Option chain shows key data for Sanara MedTech's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Sanara MedTech.

Sanara MedTech (NASDAQ:SMTI) Stock, Option Chain

Sanara MedTech

Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.

Biotech

Earnings

Earnings Beats

Large Cap

Mid Cap

News

Health Care

Small Cap

Markets

Analyst Ratings

Trading Ideas

General

ISRG

SMTI

TMDX

Sanara MedTech Inc. (NASDAQ: SMTI), along with InfuSystem Inc., recently entered into an exclusive U.S. distribution agreement with ChemoMouthpiece, LLC.

Sanara Stock Gains From New US Distribution Deal With ChemoMouthPiece

Penny Stocks

Pre-Market Outlook

Movers

AIRT

ASYS

BLIN

BSQR

CCIV

CCNC

CLBS

CLEU

CLGN

COWN

CPSH

EBON

EDRY

FDMT

FOLD

FTFT

GMBL

Grindrod Shipping Holdings Ltd Ordinary Shares

GRIN

HUBS

IFMK

ILMN

IMGN

INPX

LGHL

LIZI

LLIT

NEXI

NOVN

ONCR

PRTA

QUIK

RELI

RKDA

SALM

TLIS

TOPS

TRCH

TRVG

TUFN

VCRA

VUZI

WAFU

ZKIN

64 Biggest Movers From Friday

Movers & Shakers

AMBO

AMPE

ANCN

ARTL

BMBL

GRNVU

INUV

30 Stocks Moving In Friday&#39;s Mid-Day Session

Sanara MedTech Inc

Press Releases

Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement with, and Minority Investment in, ChemoMouthpiece, LLC

Sanara MedTech Inc. Announces Changes to Its Board of Directors

Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates

Sanara MedTech Inc. Reports Third Quarter 2024 Results

Sanara MedTech to Present at the Piper Sandler 36th Annual Healthcare Conference on December 4th

Sanara MedTech Inc. Reports Unaudited Preliminary Results for the Fourth Quarter and Full Year 2024

Sanara MedTech Inc. Expands Executive Leadership Team with New Appointments

Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd

Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc.

Sanara MedTech to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

INFU

Advanced Biomed

Align Technology

Avanos Medical

Bioventus

Cerus

The Cooper Companies, Inc. - Common Stock

Cooper Companies

Embecta

Establishment Labs Holdings Inc. - Common Shares

Establishment Labs Hldgs

Haemonetics

ICU Medical

OrthoPediatrics

Lantheus Holdings

Merit Medical Systems, Inc. - Common Stock

Merit Medical Systems

Neogen

InspireMD

OraSure Technologies, Inc. - Common Stock

OraSure Technologies

RxSight

Solventum

Staar Surgical

TELA Bio

UFP Technologies

Utah Medical Products, Inc. - Common Stock

Utah Medical Products

VolitionRX

Dentsply Sirona

Xtant Medical Holdings, Inc. Common Stock

Xtant Medical Hldgs

Cantor Fitzgerald

HC Wainwright & Co.

Comments

Sanara MedTech

Sanara MedTech (SMTI) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga